Published in Vaccine on December 13, 2011
Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains. Front Microbiol (2016) 0.83
Protective effect of Laminaria japonica with probiotics on murine colitis. Mediators Inflamm (2014) 0.77
Maternal Supplementation with LGG Reduces Vaccine-Specific Immune Responses in Infants at High-Risk of Developing Allergic Disease. Front Immunol (2013) 0.77
Genome sequence of the immunomodulatory strain Bifidobacterium bifidum LMG 13195. J Bacteriol (2012) 0.75
Proteinaceous Molecules Mediating Bifidobacterium-Host Interactions. Front Microbiol (2016) 0.75
Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of Lactobacillus reuteri DSM 17938. Front Microbiol (2017) 0.75
Diversity of bifidobacteria within the infant gut microbiota. PLoS One (2012) 2.71
Characterisation of a Bifidobacterium strain with acquired resistance to cholate--a preliminary study. Int J Food Microbiol (2003) 2.66
Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A (2010) 2.14
Effect of the adaptation to high bile salts concentrations on glycosidic activity, survival at low PH and cross-resistance to bile salts in Bifidobacterium. Int J Food Microbiol (2004) 1.58
Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol. PLoS One (2013) 1.56
Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol Ecol (2011) 1.55
Inflammation markers and malnutrition as risk factors for infections and impaired health-related quality of life among older nursing home residents. J Am Med Dir Assoc (2009) 1.44
Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum (2007) 1.43
Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J (2009) 1.43
Some immunomodulatory effects of probiotic bacteria might be due to porcine neutrophil elastase inhibitor, a serpin present in MRS broth. Immunol Lett (2008) 1.41
Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions. Proc Natl Acad Sci U S A (2013) 1.36
Distinct Bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol (2010) 1.35
Proteomic analysis of global changes in protein expression during bile salt exposure of Bifidobacterium longum NCIMB 8809. J Bacteriol (2005) 1.35
Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus. J Food Prot (2006) 1.34
Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa-bacteria interactions. Microbiology (2010) 1.29
Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol Med Microbiol (2005) 1.27
Mucin degradation by Bifidobacterium strains isolated from the human intestinal microbiota. Appl Environ Microbiol (2008) 1.24
Bifidobacterium asteroides PRL2011 genome analysis reveals clues for colonization of the insect gut. PLoS One (2012) 1.23
Genetic basis of tetracycline resistance in Bifidobacterium animalis subsp. lactis. Appl Environ Microbiol (2010) 1.23
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Appl Environ Microbiol (2008) 1.23
Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity. PLoS One (2011) 1.21
A bile salt-resistant derivative of Bifidobacterium animalis has an altered fermentation pattern when grown on glucose and maltose. Appl Environ Microbiol (2005) 1.17
Low-pH adaptation and the acid tolerance response of Bifidobacterium longum biotype longum. Appl Environ Microbiol (2007) 1.17
Molecular analysis of tet(W) gene-mediated tetracycline resistance in dominant intestinal Bifidobacterium species from healthy humans. Appl Environ Microbiol (2006) 1.15
The F1F0-ATPase of Bifidobacterium animalis is involved in bile tolerance. Environ Microbiol (2006) 1.15
Adaptation and response of Bifidobacterium animalis subsp. lactis to bile: a proteomic and physiological approach. Appl Environ Microbiol (2007) 1.13
Antibiotic resistance in probiotic bacteria. Front Microbiol (2013) 1.13
Microbiota/host crosstalk biomarkers: regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide. PLoS One (2012) 1.07
Probiotics that modify disease risk. J Nutr (2005) 1.07
Interaction of Bifidobacterium bifidum LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression. Appl Environ Microbiol (2012) 1.06
Molecular characterization of intrinsic and acquired antibiotic resistance in lactic acid bacteria and bifidobacteria. J Mol Microbiol Biotechnol (2008) 1.05
Characterisation of the exopolysaccharide (EPS)-producing Lactobacillus paraplantarum BGCG11 and its non-EPS producing derivative strains as potential probiotics. Int J Food Microbiol (2012) 1.04
Screening of exopolysaccharide-producing Lactobacillus and Bifidobacterium strains isolated from the human intestinal microbiota. Appl Environ Microbiol (2007) 1.02
Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion. J Food Prot (2005) 1.01
Genomic overview and biological functions of exopolysaccharide biosynthesis in Bifidobacterium spp. Appl Environ Microbiol (2013) 1.01
Manufacturing process influences properties of probiotic bacteria. Br J Nutr (2010) 1.00
Bile-inducible efflux transporter from Bifidobacterium longum NCC2705, conferring bile resistance. Appl Environ Microbiol (2009) 0.99
Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation. Appl Environ Microbiol (2012) 0.99
Influence of Atg5 mutation in SLE depends on functional IL-10 genotype. PLoS One (2013) 0.97
The cell-envelope proteome of Bifidobacterium longum in an in vitro bile environment. Microbiology (2009) 0.96
Two different tetracycline resistance mechanisms, plasmid-carried tet(L) and chromosomally located transposon-associated tet(M), coexist in Lactobacillus sakei Rits 9. Appl Environ Microbiol (2008) 0.96
Improved cloning vectors for bifidobacteria, based on the Bifidobacterium catenulatum pBC1 replicon. Appl Environ Microbiol (2008) 0.96
Cell envelope changes in Bifidobacterium animalis ssp. lactis as a response to bile. FEMS Microbiol Lett (2007) 0.96
Systemic lupus erythematosus in Asturias, Spain: clinical and serologic features. Medicine (Baltimore) (2006) 0.96
Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol Med Microbiol (2008) 0.95
Characterization and in vitro properties of potentially probiotic Bifidobacterium strains isolated from breast-milk. Int J Food Microbiol (2010) 0.95
Comparison of four methods to enumerate probiotic bifidobacteria in a fermented food product. Food Microbiol (2005) 0.95
Induction of alpha-L-arabinofuranosidase activity by monomeric carbohydrates in Bifidobacterium longum and ubiquity of encoding genes. Arch Microbiol (2006) 0.94
Bile affects the synthesis of exopolysaccharides by Bifidobacterium animalis. Appl Environ Microbiol (2008) 0.94
Deep 16S rRNA metagenomics and quantitative PCR analyses of the premature infant fecal microbiota. Anaerobe (2012) 0.93
Structure of the high molecular weight exopolysaccharide produced by Bifidobacterium animalis subsp. lactis IPLA-R1 and sequence analysis of its putative eps cluster. Carbohydr Res (2011) 0.93
Dexamethasone upregulates FOXP3 expression without increasing regulatory activity. Immunobiology (2010) 0.92
Ability of Bifidobacterium strains with acquired resistance to bile to adhere to human intestinal mucus. Int J Food Microbiol (2005) 0.92
Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp. Mol Nutr Food Res (2013) 0.92
Facultative to strict anaerobes ratio in the preterm infant microbiota: a target for intervention? Gut Microbes (2012) 0.92
Lactobacillus plantarum extracellular chitin-binding protein and its role in the interaction between chitin, Caco-2 cells, and mucin. Appl Environ Microbiol (2010) 0.91
Proteomics of stress response in Bifidobacterium. Front Biosci (2008) 0.91
Extracellular molecular effectors mediating probiotic attributes. FEMS Microbiol Lett (2014) 0.91
Evaluation of the functional potential of Weissella and Lactobacillus isolates obtained from Nigerian traditional fermented foods and cow's intestine. Int J Food Microbiol (2011) 0.90
Probiotic bacteria may become dormant during storage. Appl Environ Microbiol (2005) 0.90
Adhesion properties and competitive pathogen exclusion ability of bifidobacteria with acquired acid resistance. J Food Prot (2006) 0.89
Assessment of intestinal microbiota of full-term breast-fed infants from two different geographical locations. Early Hum Dev (2011) 0.89
How do bifidobacteria counteract environmental challenges? Mechanisms involved and physiological consequences. Genes Nutr (2011) 0.89